In light of our recent finding that inhibition of CXCR4/PLC-mediated signaling enhances Dex sensitivity in B-ALL cells [19], we hypothesized that defective metabolism and mitochondrial pathways may be associated with this mechanism. The gene discussed is HSPG2; the disease is acute lymphoblastic leukemia.